Author/Authors :
Moshafi، M. H. نويسنده 3Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran , , Bahador، N. نويسنده 1Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutics Research Center, Kerman University of Medical Sciences, Kerman, Islamic Republic of Iran Bahador, N. , Moghimi، S. نويسنده , , Ejtemaei، R. نويسنده 2Drug Design and Development Research Center, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran Ejtemaei, R. , Foroumadi، A. نويسنده Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, I.R.Iran. , , Asadipour، A. نويسنده Kerman Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, I.R.Iran. ,
Abstract :
In this report, a new series of fluoroquinolone agents which was derived from levofloxacin was synthesized and evaluated against Gram-positive (Bacillus subtillis, Staphylococcus aureus, Staphylococcus epidermidis and Micrococcus luteus) and Gram-negative (Esherichio coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Serratia marcescens) organisms. The results showed that some of the synthesized compounds are strong antibacterial agents. All the synthesized compounds showed remarkable activities against Staphylococcus epidermidis and Staphylococcus aureus (MIC = 0.03-1 µg/mL and 0.06-1 µg/mL respectively).
